Merck & Co. Inc. continues to cooperate with the Federal Trade
Commission after it received a Civil Investigative Demand
regarding a patent settlement agreement it entered with Ranbaxy
Laboratories Ltd.,…
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.